SPOTLIGHT: FDA forces contract manufacturer to reform

Contract manufacturer Scientific Laboratories is in a world of hurt today, as FDA has barred it from manufacturing or distributing drug products until it brings its operations up to par. The company, which makes various prescription cough-and-cold meds, didn't ask FDA for approval for some of its drugs--a dozen of them--and didn't comply with required manufacturing protocols. The consent decree Scientific Labs signed requires it to get the FDA's blessing for any product it sells and to conform to good manufacturing practices. The drugs it's already made all have to be destroyed. And the agreement comes with a big or-else: If Scientific Labs doesn't comply, FDA can shut it down completely. Story | Item

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.